Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

382 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical correlates of lifetime and current comorbidity patterns in autoimmune and inflammatory diseases.
Hässler S, Lorenzon R, Binvignat M, Ribet C, Roux A, Johanet C, Amouyal C, Amselem S, Berenbaum F, Benveniste O, Cacoub P, Grateau G, Hartemann A, Saadoun D, Salem JE, Sellam J, Seksik P, Vicaut E, Mariotti-Ferrandiz E, Rosenzwajg M, Klatzmann D. Hässler S, et al. Among authors: klatzmann d. J Autoimmun. 2024 Dec;149:103318. doi: 10.1016/j.jaut.2024.103318. Epub 2024 Oct 1. J Autoimmun. 2024. PMID: 39357469 Free article.
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial.
Lorenzon R, Ribet C, Pitoiset F, Aractingi S, Banneville B, Beaugerie L, Berenbaum F, Cacoub P, Champey J, Chazouilleres O, Corpechot C, Fautrel B, Mekinian A, Regnier E, Saadoun D, Salem JE, Sellam J, Seksik P, Vicaut E, Rosenzwajg M, Klatzmann D. Lorenzon R, et al. Among authors: klatzmann d. J Autoimmun. 2024 Apr;144:103172. doi: 10.1016/j.jaut.2024.103172. Epub 2024 Feb 7. J Autoimmun. 2024. PMID: 38330545
Low-dose interleukin-2 in patients with bipolar depression: A phase 2 randomised double-blind placebo-controlled trial.
Leboyer M, Foiselle M, Tchitchek N, Tamouza R, Lorenzon R, Richard JR, Arrouasse R, Le Corvoisier P, Le Dudal K, Vicaut E, Ellul P, Rosenzwajg M, Klatzmann D. Leboyer M, et al. Among authors: klatzmann d. Brain Behav Immun. 2025 Jan;123:177-184. doi: 10.1016/j.bbi.2024.09.005. Epub 2024 Sep 4. Brain Behav Immun. 2025. PMID: 39242054 Clinical Trial.
Interleukin-1 regulates follicular T cells during the germinal center reaction.
Belbezier A, Engeroff P, Fourcade G, Vantomme H, Vaineau R, Gouritin B, Bellier B, Brocheriou I, Tchitchek N, Graff-Dubois S, Klatzmann D. Belbezier A, et al. Among authors: klatzmann d. Front Immunol. 2024 May 24;15:1393096. doi: 10.3389/fimmu.2024.1393096. eCollection 2024. Front Immunol. 2024. PMID: 38855101 Free PMC article.
Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease.
Zhao TX, Sriranjan RS, Tuong ZK, Lu Y, Sage AP, Nus M, Hubsch A, Kaloyirou F, Vamvaka E, Helmy J, Kostapanos M, Jalaludeen N, Klatzmann D, Tedgui A, Rudd JHF, Horton SJ, Huntly BJP, Hoole SP, Bond SP, Clatworthy MR, Cheriyan J, Mallat Z. Zhao TX, et al. Among authors: klatzmann d. NEJM Evid. 2022 Jan;1(1):EVIDoa2100009. doi: 10.1056/EVIDoa2100009. Epub 2021 Nov 22. NEJM Evid. 2022. PMID: 38319239 Clinical Trial.
382 results